한미약품, 오가논과 527억 규모 치료제 공급 계약

This 10-year partnership highlights Hanmi Pharm's strategic expansion into the Southeast Asian market to address the growing demand for chronic disease management. The deal with Organon signifies the global trust in Korean pharmaceutical quality and establishes a long-term stable supply chain in the region.